Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries | 5 | 2022 | 167 | 2.780 |
Why?
|
| Heart-Assist Devices | 3 | 2022 | 822 | 0.970 |
Why?
|
| Intracranial Hemorrhages | 2 | 2021 | 132 | 0.860 |
Why?
|
| Corpus Callosum | 1 | 2021 | 59 | 0.740 |
Why?
|
| Perfusion Imaging | 1 | 2021 | 50 | 0.730 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2020 | 16 | 0.720 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 232 | 0.660 |
Why?
|
| Sepsis | 1 | 2023 | 330 | 0.660 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 102 | 0.650 |
Why?
|
| Critical Care | 1 | 2022 | 385 | 0.650 |
Why?
|
| Herpes Simplex | 1 | 2020 | 203 | 0.640 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 300 | 0.630 |
Why?
|
| Neuroimaging | 2 | 2025 | 126 | 0.390 |
Why?
|
| Humans | 13 | 2025 | 90568 | 0.240 |
Why?
|
| Sepsis-Associated Encephalopathy | 1 | 2023 | 2 | 0.220 |
Why?
|
| Head Injuries, Penetrating | 1 | 2025 | 65 | 0.220 |
Why?
|
| Wounds, Gunshot | 1 | 2025 | 110 | 0.210 |
Why?
|
| Brain Death | 1 | 2023 | 83 | 0.210 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 163 | 0.200 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2022 | 18 | 0.200 |
Why?
|
| Hemosiderin | 1 | 2021 | 2 | 0.190 |
Why?
|
| Family | 1 | 2023 | 324 | 0.190 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2021 | 10 | 0.190 |
Why?
|
| Intracranial Pressure | 1 | 2022 | 88 | 0.190 |
Why?
|
| Monitoring, Physiologic | 1 | 2022 | 265 | 0.180 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2021 | 99 | 0.180 |
Why?
|
| Middle Aged | 6 | 2025 | 26327 | 0.180 |
Why?
|
| Seizures | 1 | 2023 | 308 | 0.180 |
Why?
|
| Male | 7 | 2025 | 42931 | 0.180 |
Why?
|
| Retrospective Studies | 4 | 2025 | 9323 | 0.180 |
Why?
|
| Acyclovir | 1 | 2020 | 108 | 0.170 |
Why?
|
| Female | 7 | 2025 | 46855 | 0.170 |
Why?
|
| Central Nervous System | 1 | 2020 | 154 | 0.170 |
Why?
|
| Simplexvirus | 1 | 2020 | 151 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 163 | 0.160 |
Why?
|
| Glatiramer Acetate | 1 | 2018 | 14 | 0.150 |
Why?
|
| Prevalence | 1 | 2021 | 1251 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1873 | 0.140 |
Why?
|
| Aged | 4 | 2025 | 19404 | 0.140 |
Why?
|
| Incidence | 1 | 2021 | 1594 | 0.140 |
Why?
|
| Heart Transplantation | 1 | 2022 | 744 | 0.140 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1741 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 202 | 0.130 |
Why?
|
| Pandemics | 1 | 2022 | 788 | 0.130 |
Why?
|
| Brain | 2 | 2025 | 2327 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1735 | 0.130 |
Why?
|
| Inflammation | 1 | 2021 | 990 | 0.130 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 274 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2021 | 2893 | 0.120 |
Why?
|
| Biomarkers | 1 | 2021 | 1797 | 0.110 |
Why?
|
| Adult | 3 | 2025 | 26940 | 0.110 |
Why?
|
| Prognosis | 1 | 2021 | 3810 | 0.110 |
Why?
|
| Adolescent | 2 | 2025 | 9353 | 0.100 |
Why?
|
| Heart Failure | 1 | 2022 | 1270 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2025 | 426 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 361 | 0.040 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2018 | 58 | 0.040 |
Why?
|
| Hypoxia | 1 | 2021 | 660 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1162 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 2702 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1485 | 0.030 |
Why?
|
| Aging | 1 | 2018 | 727 | 0.030 |
Why?
|
| Young Adult | 1 | 2025 | 6425 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 5580 | 0.020 |
Why?
|
| Animals | 1 | 2021 | 27691 | 0.010 |
Why?
|